Accueil>>Signaling Pathways>> Microbiology & Virology>> Parasite>>MMV008138

MMV008138

Catalog No.GC36637

MMV008138 est un agent antipaludéen ciblant IspD (enzyme 2-C-methyl-d-erythritol 4-phosphate cytidylyltransferase) sélectif d'espèce, avec une IC50 de 44 nM pour PfIspD (P.

Products are for research use only. Not for human use. We do not sell to patients.

MMV008138 Chemical Structure

Cas No.: 1679333-73-3

Taille Prix Stock Qté
10mM (in 1mL DMSO)
459,00 $US
En stock
5mg
417,00 $US
En stock
10mg
695,00 $US
En stock
50mg
2 086,00 $US
En stock
100mg
3 105,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MMV008138 is a species-selective antimalarial agent which targets the enzyme 2- C-methyl-d-erythritol 4-phosphate cytidylyltransferase (IspD) in the MEP pathway, with an IC50 of 250 nM for P. falciparum Dd2 strain[1][2]. IC50: 250 nM (P. falciparum Dd2 strain)[1]

[1]. Ghavami M, et al. Biological Studies and Target Engagement of the 2- C-Methyl-d-Erythritol 4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent (1 R,3 S)-MMV008138 and Analogs. ACS Infect Dis. 2018 Apr 13;4(4):549-559. [2]. Yao ZK, et al. Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure-activity studies. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1515-9.

Avis

Review for MMV008138

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MMV008138

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.